Shenzhen, China

Lei Chen

USPTO Granted Patents = 120 

 

 

Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 106(Granted Patents)

DiyaCoin DiyaCoin 0.32 


Inventors with similar research interests:


Location History:

  • Hong Kong, CN (2019 - 2022)
  • Chengdu, CN (2014 - 2023)
  • Guangdong, CN (2016 - 2023)
  • Xi'an, CN (2023)
  • Shenzhen, CN (2015 - 2024)
  • Dongguan, CN (2019 - 2024)

Company Filing History:


Years Active: 2014-2025

where 'Filed Patents' based on already Granted Patents

120 patents (USPTO):

Title: Lei Chen: Innovating in Pharmaceutical Chemistry

Introduction:

Lei Chen, based in Dongguan, China, has established himself as an inventive force in the field of pharmaceutical chemistry. With a passion for developing new materials and innovative processes, he has made significant contributions to his industry. Working at Sunshine Lake Pharma Co., Ltd., Chen has consistently created groundbreaking solutions and holds two patents for his recent discoveries. This article will delve into his latest patents, career highlights, and collaborations, shedding light on his exceptional contributions to the field of pharmaceutical research and development.

Latest Patents:

Lei Chen's latest patents showcase his expertise and novel approaches in the field of pharmaceutical chemistry. His most recent patents include the invention of a sacubitril intermediate and its preparation method. This intermediate serves as a crucial component in the synthesis of sacubitril, a valuable compound used in the pharmaceutical industry. The method developed by Chen offers several advantages, including easy accessibility to raw materials, a simple preparation process, cost-effectiveness, and environmental friendliness. These patents highlight Chen's ability to create practical solutions with significant potential in industrial production.

Career Highlights:

Lei Chen's career is marked by his dedication to advancing pharmaceutical chemistry. His work at Sunshine Lake Pharma Co., Ltd. has been instrumental in driving innovation within the company. Through his tireless efforts, Chen has not only obtained patents but has also contributed to the development and commercialization of new pharmaceutical products. His accomplishments are a testament to his deep knowledge and expertise in the field.

Collaborations:

Successful innovation often stems from collaboration, and Lei Chen recognizes the value of working with peers to create breakthroughs. Notable among his collaborations are his colleagues Guodong Sun and Xiaodong Han. Working together, they have shared their expertise and insights to tackle complex challenges and develop novel solutions. These collaborations showcase Chen's ability to foster teamwork and bring together talented individuals from diverse backgrounds for greater innovation.

Conclusion:

Lei Chen's passion for pharmaceutical chemistry has driven him to make significant contributions to the field. With two patents, including his groundbreaking work on the sacubitril intermediate and its preparation method, Chen has proven himself as an inventive and capable researcher. His dedication to improving the pharmaceutical industry, along with his collaborations with esteemed colleagues like Guodong Sun and Xiaodong Han, highlights his commitment to innovation. Lei Chen's impressive achievements underscore his immense potential for future breakthroughs and his status as a valuable asset in the world of pharmaceutical chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…